Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast

J W Meakin; W E Allt; F A Beale; R S Bush; R M Clark; P J Fitzpatrick; N V Hawkins; R D Jenkin; J F Pringle; J G Reid; W D Rider

doi:10.1007/978-3-642-81332-0_17

Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast

Recent Results Cancer Res. 1978:68:118-22. doi: 10.1007/978-3-642-81332-0_17.

Authors

J W Meakin, W E Allt, F A Beale, R S Bush, R M Clark, P J Fitzpatrick, N V Hawkins, R D Jenkin, J F Pringle, J G Reid, W D Rider

PMID: 752852
DOI: 10.1007/978-3-642-81332-0_17

Abstract

Following surgery and regional radiotherapy for operable carcinoma of the breast in premenopausal women, ovarian irradiation (2000 rad in five daily fractions) plus prednisone (7.5 mg per day) results in delayed recurrence and prolonged survival.

Publication types

Comparative Study

MeSH terms

Adult
Breast Neoplasms / drug therapy
Breast Neoplasms / radiotherapy*
Breast Neoplasms / surgery
Female
Humans
Lymphatic Metastasis
Menopause
Middle Aged
Ovary / radiation effects*
Prednisone / therapeutic use*
Radiotherapy Dosage

Substances

Prednisone